PortfoliosLab logoPortfoliosLab logo
QNTM vs. SMHX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

QNTM vs. SMHX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Quantum BioPharma Ltd (QNTM) and VanEck Fabless Semiconductor ETF (SMHX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, QNTM achieves a -47.26% return, which is significantly lower than SMHX's 64.32% return.


QNTM

1D
5.19%
1M
-58.33%
YTD
-47.26%
6M
-59.30%
1Y
-83.27%
3Y*
-64.46%
5Y*
-49.48%
10Y*

SMHX

1D
-5.60%
1M
3.65%
YTD
64.32%
6M
61.18%
1Y
113.51%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

QNTM vs. SMHX - Yearly Performance Comparison


2026 (YTD)20252024
QNTM
Quantum BioPharma Ltd
-47.26%98.37%-16.36%
SMHX
VanEck Fabless Semiconductor ETF
64.32%30.00%15.56%

Correlation

The correlation between QNTM and SMHX is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Aug 28, 2024

0.15

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

QNTM vs. SMHX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

QNTM
QNTM Risk / Return Rank: 1414
Overall Rank
QNTM Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
QNTM Sortino Ratio Rank: 1515
Sortino Ratio Rank
QNTM Omega Ratio Rank: 1717
Omega Ratio Rank
QNTM Calmar Ratio Rank: 77
Calmar Ratio Rank
QNTM Martin Ratio Rank: 1414
Martin Ratio Rank

SMHX
SMHX Risk / Return Rank: 8787
Overall Rank
SMHX Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
SMHX Sortino Ratio Rank: 8080
Sortino Ratio Rank
SMHX Omega Ratio Rank: 8181
Omega Ratio Rank
SMHX Calmar Ratio Rank: 9494
Calmar Ratio Rank
SMHX Martin Ratio Rank: 8787
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

QNTM vs. SMHX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Quantum BioPharma Ltd (QNTM) and VanEck Fabless Semiconductor ETF (SMHX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


QNTMSMHXDifference
Sharpe ratioReturn per unit of total volatility

-3.66

Sortino ratioReturn per unit of downside risk

-4.19

Omega ratioGain probability vs. loss probability

0.91

1.46

-0.54

Calmar ratioReturn relative to maximum drawdown

-0.90

6.69

-7.59

Martin ratioReturn relative to average drawdown

-1.22

17.96

-19.18

QNTM vs. SMHX - Sharpe Ratio Comparison

The current QNTM Sharpe Ratio is -0.55, which is lower than the SMHX Sharpe Ratio of 3.11. The chart below compares the historical Sharpe Ratios of QNTM and SMHX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

QNTM vs. SMHX - Drawdown Comparison

The maximum QNTM drawdown since its inception was -99.98%, which is greater than SMHX's maximum drawdown of -38.53%. Use the drawdown chart below to compare losses from any high point for QNTM and SMHX.


Loading charts...

Drawdown Indicators


QNTMSMHXDifference

Max Drawdown

Largest peak-to-trough decline

-99.98%

-38.53%

-61.45%

Max Drawdown (1Y)

Largest decline over 1 year

-92.81%

-17.06%

-75.75%

Max Drawdown (3Y)

Largest decline over 3 years

-97.98%

Max Drawdown (5Y)

Largest decline over 5 years

-98.42%

Current Drawdown

Current decline from peak

-99.96%

-7.91%

-92.05%

Average Drawdown

Average peak-to-trough decline

-92.23%

-7.34%

-84.89%

Ulcer Index

Depth and duration of drawdowns from previous peaks

68.15%

6.34%

+61.81%

Volatility

QNTM vs. SMHX - Volatility Comparison

Quantum BioPharma Ltd (QNTM) has a higher volatility of 45.52% compared to VanEck Fabless Semiconductor ETF (SMHX) at 19.93%. This indicates that QNTM's price experiences larger fluctuations and is considered to be riskier than SMHX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


QNTMSMHXDifference

Volatility (1M)

Calculated over the trailing 1-month period

45.52%

19.93%

+25.59%

Volatility (6M)

Calculated over the trailing 6-month period

110.50%

29.76%

+80.74%

Volatility (1Y)

Calculated over the trailing 1-year period

154.68%

36.70%

+117.98%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

134.20%

41.48%

+92.72%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

140.35%

41.48%

+98.87%

Dividends

QNTM vs. SMHX - Dividend Comparison

QNTM has not paid dividends to shareholders, while SMHX's dividend yield for the trailing twelve months is around 0.01%.


PositionTTM20252024
QNTM
Quantum BioPharma Ltd
0.00%0.00%0.00%
SMHX
VanEck Fabless Semiconductor ETF
0.01%0.02%0.04%

Frequently Asked Questions


QNTM and SMHX have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

QNTM has higher volatility (45.52%) compared to SMHX (19.93%). In terms of maximum drawdown, QNTM dropped -99.98% vs SMHX's -38.53%.

SMHX currently has the higher Sharpe Ratio (3.11 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for QNTM and SMHX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer